Intravenous news: News Medical report “Recent safety concerns in the preparation and delivery of parenteral nutrition (PN), commonly referred to as intravenous (IV) nutrition, prompted leaders from several major organizations to participate in a PN Safety Summit on September 23, 2011. The Summit participants agreed to several recommendations that will improve the safety of PN therapy and patient care, in the areas of PN order prescribing, order review and verification, and formulation compounding.
Hosted by the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.), the PN Safety Summit included representatives from the U.S. Food and Drug Administration, the Institute of Safe Medication Practices (ISMP), the American Society of Health-System Pharmacists, the National Home Infusion Association and industry representatives, among others. The Summit allowed experts in clinical nutrition to address the safety issues surrounding parenteral nutrition and to develop recommendations for improvement. When these therapies are not prepared with quality control measures in place, the sterility, stability and compatibility can be impacted, putting patients at risk. Preparing parenteral nutrition involves complex sterile preparations and should be handled in a carefully controlled environment with built-in quality assurance from prescribing, to formulating and delivery.”